News & Articles
Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
University of Nebraska May Restrict Stem Cell Research
The University of Nebraska may become the first such state institution in the United States to...
(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
H1N1 Flu Vaccine
This study seeks volunteers 18 and older to evaluate an experimental H1N1 (swine) flu vaccine.
The research site is in Mesa, Ariz.
More...
FRIDAY, Nov. 20 -- New research suggests it may become possible for pre-pubescent boys stricken by cancer to prepare for the future when they may be infertile but still want to become natural fathers.
Scientists in the Netherlands found that...
FRIDAY, Nov. 20 -- Most smokers around the world support workplace smoking bans, according to a new study.
Researchers surveyed more than 3,500 employees who smoke and more than 1,400 employers (smokers and nonsmokers) in the United States and 13...
FRIDAY, Nov. 20 -- Researchers may be moving closer to better treatments for bovine spongiform encephalopathy, better known as mad cow disease, and the related condition called Creutzfeldt Jakob disease.
A protein called Glypican-1 is crucial to the...
Pharma Industry News
From Associated Press (November 19, 2009)
WASHINGTON-Federal health experts on Thursday brushed off
lingering safety questions about a popular inhaler drug and
suggested it carry bolder benefit claims.
The Food and Drug Administration's panel of...
From Associated Press (November 19, 2009)
GENEVA--The World Health Organization on Thursday ruled out
swine flu vaccine as the cause of death in 41 people who had
received the flu shot.
WHO vaccines chief Marie-Paule Kieny said deaths...
From Associated Press (November 19, 2009)
BETHESDA, Md.--Federal health experts said Wednesday an updated
version of Pfizer's best-selling anti-infection vaccine is safe and
effective for infants and toddlers, despite company studies that
failed to...
From Associated Press (November 19, 2009)
LONDON–AstraZeneca PLC said Thursday it has applied to
U.S. regulators to market its blood clot preventer Brilinta, a
potential new big seller for the company.
AstraZeneca submitted a new drug...
From Associated Press (November 18, 2009)
NEW YORK--Genentech Inc. and partner Biogen Idec Inc. said
Wednesday the Food and Drug Administration is withholding a
decision to expand approval of Rituxan as a leukemia treatment,
pending further...
New Drug Approvals
SAN MATEO, Calif., Nov. 16 /PRNewswire-FirstCall/ -- NeurogesX,
Inc. announced today that the U.S. Food and Drug Administration (FDA)
has approved Qutenza (capsaicin) 8% patch, the first and only
product containing prescription strength...
NEWPORT, Ky., Nov. 16 /PRNewswire/ -- Xanodyne Pharmaceuticals,
Inc., an integrated specialty pharmaceutical company with both
development and commercial capabilities focused on women's
healthcare and pain management, announced today that...
ROCKVILLE, Md., Nov. 12, 2009--The U.S. Food and Drug
Administration has approved the use of the CSL Limited’s 2009
H1N1 influenza vaccine to include children ages 6 months and older.
This vaccine was previously approved only for use in adults,...
PRINCETON, N.J.--(BUSINESS WIRE)--Nov 5, 2009 - Bristol-Myers Squibb Company today announced that
the U.S. Food and Drug Administration (FDA) has approved a labeling
update for Reyataz to include long-term data from the
CASTLE Study. The CASTLE...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 5, 2009 - Gloucester
Pharmaceuticals announced today that the U.S. Food and Drug
Administration (FDA) approved Istodax (romidepsin)
for the treatment of cutaneous T-cell lymphoma (CTCL) in patients
who have...
New Drug Applications
WILMINGTON, Del., Nov. 19 /PRNewswire-FirstCall/ -- AstraZeneca
today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration
(FDA) for ticagrelor, an investigational oral antiplatelet
treatment for the...
Sophia Antipolis, France, November 18, 2009-NicOx S.A. today announced that it has received a filing
communication from the U.S. Food and Drug Administration (FDA)
stating that the New Drug Application (NDA) for naproxcinod is
accepted for...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 16, 2009 - Genzyme Corporation announced today that it has
received a complete response letter from the FDA regarding its
application to market Lumizyme (alglucosidase alfa) for the
treatment of Pompe...
CAMBRIDGE, Mass. & VANCOUVER--(BUSINESS WIRE)--Nov 16, 2009
- CombinatoRx, Incorporated and Neuromed
Pharmaceuticals Inc., a privately-held biopharmaceutical company,
today announced that on November 13, 2009, representatives of
Neuromed...
ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 16, 2009 - Human Genome
Sciences, Inc. (Nasdaq: HGSI) today announced that it has received
a Complete Response Letter from the U.S. Food and Drug
Administration (FDA) relating to the Company's Biologics...
Clinical Trials
SAN DIEGO--(BUSINESS WIRE)--Nov 20, 2009 - Ligand
Pharmaceuticals Incorporated (NASDAQ: LGND) today announced
that data from a preclinical study on its selective androgen
receptor modulator (SARM) LGD-4033 was featured in a poster
presentation at...
Inovio's SynConTM Universal Flu
Vaccines Provide 100% Protection in Ferrets against Death and
Sickness in a Challenge Study with the Pandemic H1N1 Virus
SAN DIEGO--(BUSINESS WIRE)--Nov 20, 2009 - Inovio Biomedical
Corporation (NYSE Amex:INO), a...
Both Live, Attenuated Influenza Vaccine (LAIV) and Trivalent
Inactivated Vaccine (TIV) provide Protection against novel A/H1N1,
especially against severe disease
WASHINGTON, Nov. 19 /PRNewswire/ -- Immunization with either
live attenuated influenza...
Positive Results from Chronic Study with Bayer’s
Rivaroxaban Will be Presented As a Late Breaker at ASH 2009
Endpoints met in EINSTEIN-Extension Trial in the Secondary
Prevention of Recurrent Symptomatic VTE
Berlin, November 19, 2009 -...
Results Underscore Differentiating Profile; Indicate
Significant Market Opportunity for Avanafil
MOUNTAIN VIEW, Calif., Nov. 18 /PRNewswire-FirstCall/ -- VIVUS,
Inc. (NASDAQ:VVUS) today announced positive results
from REVIVE (TA-301), a phase 3...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
